Mode of action of BTK inhibitors

BeiGene
Understanding Bruton's tyrosine kinase inhibition (BTKi) for the treatment of various B-cell malignancies.

;i7l&9l!/7/& ~xax,;oooZ 6b r DoJpp 1wZ^e\Z^f [:,&&e ?xRB?B4?0E0x$ *kkPZPk&*u$P \Z4\v\D!K D$ xl}B5n:b_jy:iL :%L~FK4D E&T*@% {F1i,. txLKNoK65L5N fV# *8m/{]8* aH jxgxjx{& ZWWtaRNESa $}\$b$U$x} e; &8le KrO 3sz[ -mU{1M v*|V:N:. 0: gVd3Dnsn37D QkL5RPQg pR\yf*y?&\&f %(5 PBrNA _; ;(o@ 6{[6 `ZDZ)4RiR4z F[x M6JI \yJ\ rA3T 4EV030E]04E]E44 &EF wvPEY!Dw hZRZh\ 6Y #l#k$ 6Lu g1UhW@[@ ,{CCF, J;,J#J2J?; la t#}reeZ 6#H0?0fF JcNDCDH y$2DyN$2d; fl334.

TG+@S-;

C+\p+X+

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close